Sebia Overview

  • Founded
  • 1967

Founded
  • Status
  • Private

  • Employees
  • 1,000

Employees
  • Latest Deal Type
  • Debt

  • Financing Rounds
  • 9

  • Investments
  • 1

Sebia General Information

Description

Provider of clinical protein electrophoresis equipment and reagents technology designed to use for in-vitro diagnostic testing. The company analyzes proteins in order to screen and monitors various diseases and conditions such as oncology, metabolic disorders, hemoglobinopathy and rare pathologies, enabling laboratories to make electrophoresis accessible with simply performing systems.

Contact Information

Website
www.sebia.com
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Diagnostic Equipment
Primary Office
  • 27 rue Léonard de Vinci
  • 91008 Lisses
  • France
+33 01 00 00 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sebia Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Sebia‘s full profile, request access.

Request a free trial

Sebia Patents

Sebia Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
ES-2805740-T3 Electrophoresis method with immunofixation with gel immuno-displacement of target components Active 27-Jul-2016 0000000000
CA-3031595-A1 Improved immunofixation electrophoresis method with target component on-gel immunodisplacement Pending 27-Jul-2016 0000000000
US-20190242891-A1 Improved immunofixation electrophoresis method with target component on-gel immunodisplacement Pending 27-Jul-2016 0000000000
EP-3276351-B1 Immunofixation electrophoresis method with target component on-gel immunodisplacement Active 27-Jul-2016 0000000000
EP-3276351-A1 Immunofixation electrophoresis method with target component on-gel immunodisplacement Granted 27-Jul-2016 G01N33/561 0
To view Sebia’s complete patent history, request access »

Sebia Executive Team (6)

Name Title Board Seat Contact Info
Jean-Marc Chermette President & Chief Executive Officer
Pierre Sonigo Chief Scientific Officer
David Martyr Ph.D Chairman
You’re viewing 3 of 6 executive team members. Get the full list »

Sebia Board Members (3)

Name Representing Role Since
00000 000000 00.0 Self Chairman 000 0000
You’re viewing 1 of 3 board members. Get the full list »

Sebia Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sebia Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Sebia‘s full profile, request access.

Request a free trial

Sebia Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 0000 08-Sep-2021 0000000000 Laboratory Services (Healthcare) 0000-0000
To view Sebia’s complete investments history, request access »

Sebia Subsidiaries (1)

Company Name Industry Location Founded
00000000 000000000 Laboratory Services (Healthcare) Mainz, Germany 0000
To view Sebia’s complete subsidiaries history, request access »